关注
Dr Venkata Narasayya Saladi, General Manager and Head Physical R&D
Dr Venkata Narasayya Saladi, General Manager and Head Physical R&D
Lee Pharma Limited and SRM Institute of Science and Technologies
在 msnlabs.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
In situ metastable form: a route for the generation of hydrate and anhydrous forms of ceritinib
R Chennuru, RT Koya, P Kommavarapu, SV Narasayya, P Muthudoss, ...
Crystal Growth & Design 17 (12), 6341-6352, 2017
172017
Novel pharmaceutical Cocrystal of Apalutamide, a nonsteroidal antiandrogen drug: Synthesis, crystal structure, dissolution, stress, and excipient compatibility
VN Saladi, BR Kammari, PR Mandad, GR Krishna, E Sajja, RS Thirumali, ...
Crystal Growth & Design 22 (2), 1130-1142, 2022
152022
Preparation, Pharmaceutical Properties and Stability of Lesinurad Co-crystals and Solvate
SV Narasayya, A Maruthapillai, D Sundaramurthy, JA Selvi, S Mahapatra
Materials Today: Proceedings 14, 532-544, 2019
42019
Solid dispersions for solubility and bioavailability enhancement of poorly aqueous soluble drugs: A review
AM Pavan Kommavarapu, K Palanisamy, VN Saladi, RT Koya
International Journal of Advanced Chemical Science and Applications 2, 8-15, 2014
32014
Stable Fatty Acid Solvates of Dasatinib, a Tyrosine Kinase Inhibitor: Prediction, Process, and Physicochemical Properties
VN Saladi, BR Kammari, A Maruthapillai, S Mahapatra, R Chennuru, ...
ACS omega 7 (8), 7032-7044, 2022
22022
Discovery of a novel and pharmaceutically viable propylene glycol solvate of Idelalisib
SV Narasayya, A Maruthapillai, S Mahapatra
Materials Today: Proceedings 34, 510-515, 2021
12021
Alternate solid form synthesis, characterization and stability of phosphodiesterase 4 inhibitor
SV Narasayya, R Koya, A Maruthapillai, D Sundaramurthy, S Mahapatra
Materials Today: Proceedings 40, S139-S147, 2021
12021
Novel crystalline polymorphs of 1-[(3r)-3-[4-amino-3-(4-phenoxyphenyl)-1h-pyrazolo [3, 4-d] pyrimidin-1-yl]-1-piperidinyl]-2-propen-1-one and process for preparation thereof
TR Srinivasan, E Sajja, V T MATHAD, RR Sagyam, S Rangineni, ...
US Patent App. 17/432,938, 2024
2024
Novel Pharmaceutical Cocrystal of Voxelotor, a Hemoglobin Oxygen Affinity Modulator: Synthesis, Crystal Structure, and Physicochemical Properties
BR Kammari, VN Saladi, A Garai, RR Sagyam, RT Srinivasan, VT Mathad
Crystal Growth & Design 23 (11), 8065-8075, 2023
2023
Novel crystalline forms of 2-{3-[4-(1H-indazol-5-ylamino)-2-quinazolinyl] phenoxy}-N-(propan-2-yl) acetamide mesylate
ST Rajan, S Eswaraiah, VT Mathad, SR Reddy, KNK Reddy, ...
2023
Crystalline forms of N-(4-(6, 7-dimethoxyquinolin-4-yloxy) phenyl)-N’-(4 fluorophenyl) cyclopropane-1, 1-dicarboxamide salts and process for its preparation thereof
ST Rajan, S Eswaraiah, VT Mathad, SV Narasayya, KB Raju
2023
Acid addition salts of Belumosudil and their process for the preparation thereof
ST Rajan, S Eswaraiah, VT Mathad, SV Narasayya, K Balraju, G Abhijit
2023
Process for the preparation of amorphous form of Risdiplam
ST Rajan, S Eswaraiah, VT Mathad, SV Narasayya, K Balraju
2023
Novel polymorphs of Voxelotor and their processes for preparation thereof
ST Rajan, S Eswaraiah, VT Mathad, SV Narasayya, K Balraju
2023
Polymorphs of 7-cyclopentyl-n, n-dimethyl-2-{[5-(piperazin-1-yl) pyridin-2-yl]-amino}-7h-pyrrolo [2, 3-d] pyrimidine-6-carboxamide and its pharmaceutically acceptable salts and …
TR Srinivasan, E Sajja, S Revu, RR Sagyam, S Rangineni, R Srinivasan, ...
US Patent App. 17/606,827, 2022
2022
Novel crystalline polymorphs of sodium (4r, 12as)-9-{[(2, 4-difluorophenyl) methyl] carbamoyl}-4-methyl-6, 8-dioxo-3, 4, 6, 8, 12, 12a-hexahydro-2h-pyrido [1', 2': 4, 5 …
TR Srinivasan, E Sajja, RR Sagyam, S Ragineni, VN Saladi
US Patent App. 17/428,745, 2022
2022
Novel process for the preparation of methyl N-{(2S)-1-[(4-{3-[5-chloro-2-fluoro-3 (methanesulfonamido) phenyl]-1-(propan-2-yl)-1H-pyrazol-4-yl} pyrimidin-2-yl) amino] propan …
ST Rajan, S Eswaraiah, VT Mathad, SV Narasayya, KB Raju, ...
2022
PROCESS FOR THE PREPARATION OF GILTERITINIB FUMARATE
2022
Process for the preparation of crystal modification 3 of (R)-3-(4-(7H-pyrrolo [2, 3 d] pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile hydrochloride
ST Rajan, S Eswaraiah, VT Mathad, SV Narasayya, KB Raju
2022
Solid state forms of Lenvatinib Mesylate
SV NARASAYYA, VK Mudapaka, V Peddy
US Patent 11,084,791, 2021
2021
系统目前无法执行此操作,请稍后再试。
文章 1–20